Covered recipient · General Payments record
STEVE S LEE
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$16,050.18
- Reported across 67 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $712.31 | 8 |
| Consulting Fee | $680.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $680.00 | 1 |
| Aurinia Pharma U.S., Inc. | $169.91 | 2 |
| Janssen Biotech, Inc. | $145.61 | 1 |
| ABBVIE INC. | $124.58 | 1 |
| PFIZER INC. | $120.00 | 1 |
| GlaxoSmithKline, LLC. | $75.26 | 1 |
| Acerta Pharma LLC | $49.27 | 1 |
| UCB, Inc. | $27.68 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $124.58 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104156312 | CMS |
| AstraZeneca Pharmaceuticals LP | $49.27 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105857860 | CMS |
| Aurinia Pharma U.S., Inc. | $88.01 | 01/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150686057 | CMS |
| Aurinia Pharma U.S., Inc. | $81.90 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150686059 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $680.00 | 10/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1117968489 | CMS |
| GlaxoSmithKline, LLC. | $75.26 | 09/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116331819 | CMS |
| Janssen Biotech, Inc. | $145.61 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078295305 | CMS |
| PFIZER INC. | $120.00 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130878490 | CMS |
| UCB, Inc. | $27.68 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143237243 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.